Sciton, Inc · Lasers & Light
510(k) · clearedClass IIK032460
Cleared2003Studies1,028Trials43
Devices linked to vascular
7 products · matched by keyword rule, not the cleared indication
7 products
Cynosure, Inc. · Lasers & Light
510(k) · clearedClass IIK050779EU
Cleared2005Studies1,530Trials72
Alma Lasers, Inc. · Lasers & Light
510(k) · clearedClass IIK243044
Cleared2008Studies1,028Trials43
Cynosure, Inc. · Lasers & Light
510(k) · clearedClass IIK142376EU
Cleared2011Studies1,028Trials43
Candela Corporation · Lasers & Light
510(k) · clearedClass IIK212492EU
Cleared2015Studies1,028Trials43
Lumenis Be, Ltd. · Lasers & Light
510(k) · clearedClass IIK250809EU
Cleared2015Studies1,028Trials43
Candela Corporation · Lasers & Light
510(k) · clearedClass IIK230990EU
Cleared2002Studies1,530Trials72
| Product | Manufacturer | Category | Pathway | Class | First decision | Studies | Trials |
|---|---|---|---|---|---|---|---|
| BBL | Sciton, Inc | Lasers & Light | 510(k) — cleared | Class II | Nov 13 2003 | 1,028 | 43 |
| Cynergy EU | Cynosure, Inc. | Lasers & Light | 510(k) — cleared | Class II | Jan 12 2005 | 1,530 | 72 |
| Harmony XL | Alma Lasers, Inc. | Lasers & Light | 510(k) — cleared | Class II | May 23 2008 | 1,028 | 43 |
| Icon EU | Cynosure, Inc. | Lasers & Light | 510(k) — cleared | Class II | Jun 22 2011 | 1,028 | 43 |
| Nordlys EU | Candela Corporation | Lasers & Light | 510(k) — cleared | Class II | Jul 7 2015 | 1,028 | 43 |
| Stellar M22 EU | Lumenis Be, Ltd. | Lasers & Light | 510(k) — cleared | Class II | Jan 21 2015 | 1,028 | 43 |
| Vbeam EU | Candela Corporation | Lasers & Light | 510(k) — cleared | Class II | Feb 11 2002 | 1,530 | 72 |
No product matches these filters.
Missing a device? Report it and it goes into the monthly review.
Curated seed list; study and trial counts are per modality, not per brand. What this measuresThis is a curated seed list of widely used medical-aesthetic products, each crosswalked to a real FDA record where one could be found with confidence. Being listed is not an endorsement, not a ranking and not a claim of market share. Being absent is not a judgement — it means the product is not in this seed list yet. Counts beside each filter are live counts of the products currently matching your other filters. Manufacturer is the applicant or sponsor field of the FDA record, printed exactly as FDA publishes it, so one company can appear under more than one string.
Methodology →
Sorted by most recent FDA decision — a filing date, not a quality signal. What each ordering measuresEvery ordering on this page is a proxy built from public records, never a quality judgement. Orders products by the most recent FDA decision date matched to the brand name, including later submissions and supplements. A recent date means the manufacturer filed again; it does not mean the product is newer, improved, more popular or better. Orders products by the number of PubMed records matching a fixed query for the product's MODALITY, never its brand name. It counts how much has been published about a technique. It is not a quality score, not an efficacy measure, not a count of randomised trials, and not comparable between techniques of different ages. Orders products by the number of ClinicalTrials.gov studies matching a fixed intervention-plus-condition query for the product's MODALITY, never its brand. Registration is not completion, not publication and not a result. Alphabetical by product name. No ranking, quality judgement or ordering of merit is implied by the position of anything in this list. Orders products by the earliest FDA decision date matched to the brand name. For drugs approved under a BLA or NDA the original approval can long predate any cosmetic indication, so an early date is not a cosmetic-use date.
Methodology →
How each product matched (7)
| Product | Matched term | Source string |
|---|---|---|
| BBL | rosacea | ClinicalTrials.gov condition query for IPL / broadband light |
| Cynergy | port wine stain | ClinicalTrials.gov condition query for Pulsed dye laser |
| Harmony XL | rosacea | ClinicalTrials.gov condition query for IPL / broadband light |
| Icon | rosacea | ClinicalTrials.gov condition query for IPL / broadband light |
| Nordlys | rosacea | ClinicalTrials.gov condition query for IPL / broadband light |
| Stellar M22 | rosacea | ClinicalTrials.gov condition query for IPL / broadband light |
| Vbeam | port wine stain | ClinicalTrials.gov condition query for Pulsed dye laser |
Derived by keyword rule from real source strings, not the cleared indication. What this measuresTreatment areas are DERIVED, not copied from an FDA field. A fixed keyword list is run over two real strings: the ClinicalTrials.gov condition query actually executed for this product's modality on the run date, and the device names of the FDA product codes attached to this product's records. The words "skin" and "cosmetic" are ignored because every query contains one of them. An area is not the cleared or approved indication — openFDA's 510(k) response does not carry the indications-for-use text, and this Index does not paraphrase it. Products whose source query names port wine stains, rosacea, telangiectasia or haemangioma.
Methodology →